Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients
Clinical trial NCT00369382 · COMPLETED
Trial details
- NCT number
- NCT00369382
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2010-04-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.